当前位置:首页 - 行情中心 - 昭衍新药(603127) - 财务分析

昭衍新药

(603127)

  

流通市值:233.22亿  总市值:277.23亿
流通股本:6.30亿   总股本:7.49亿

昭衍新药(603127)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润0.81亿元,每股收益0.11元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益812102.22万元,未分配利润215328.99万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产953338.27万元,负债141236.05万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入984,961,529.76668,575,211.14287,337,235.012,018,333,771.81
营业总成本1,025,427,901.11667,394,336.77288,252,886.211,763,748,341.31
其他经营收益
营业利润99,452,028.3479,855,509.3649,382,588.17104,347,309.12
利润总额99,625,384.8280,119,573.7549,383,749.8104,039,073.62
净利润80,706,047.3260,932,376.3841,119,465.2569,755,063.9
每股收益
其他综合收益-6,480,220.42-2,334,068.82-766,939.36-51,041,084.41
综合收益总额74,225,826.958,598,307.5640,352,525.8918,713,979.49
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计5,313,064,269.175,279,952,786.465,063,761,087.585,031,197,927.38
非流动资产:
非流动资产合计4,220,318,440.054,193,509,475.844,360,897,521.944,364,954,683.07
资产总计9,533,382,709.229,473,462,262.39,424,658,609.529,396,152,610.45
流动负债:
流动负债合计1,220,473,990.191,167,148,440.511,097,659,363.431,110,568,596.28
非流动负债:
非流动负债合计191,886,482.35201,247,346.06217,793,323.03206,395,760.21
负债合计1,412,360,472.541,368,395,786.571,315,452,686.461,316,964,356.49
所有者权益(或股东权益):
归属于母公司股东权益合计8,120,652,590.128,104,696,831.488,108,836,282.88,078,818,586.72
股东权益合计8,121,022,236.688,105,066,475.738,109,205,923.068,079,188,253.96
负债和股东权益合计9,533,382,709.229,473,462,262.39,424,658,609.529,396,152,610.45
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计1,323,471,987.19875,978,571.86429,804,957.521,811,387,046.15
经营活动现金流出小计1,057,080,837.87713,205,577.03364,655,756.361,472,458,327.75
经营活动产生的现金流量净额266,391,149.32162,772,994.8365,149,201.16338,928,718.4
投资活动产生的现金流量:
投资活动现金流入小计1,966,983,491.981,038,476,224.2617,613,712.483,365,501,966.77
投资活动现金流出小计2,231,706,104.471,473,488,544.15951,573,490.955,328,525,952.31
投资活动产生的现金流量净额-264,722,612.49-435,012,319.95-333,959,778.47-1,963,023,985.54
筹资活动产生的现金流量:
筹资活动现金流入小计----
筹资活动现金流出小计58,988,545.9128,180,254.5718,665,128.1265,627,486.97
筹资活动产生的现金流量净额-58,988,545.91-28,180,254.57-18,665,128.1-265,627,486.97
汇率变动对现金及现金等价物的影响-5,822,610.67-2,551,375.3-1,154,223.861,278,854.73
现金及现金等价物净增加额-63,142,619.75-302,970,954.99-288,629,929.27-1,888,443,899.38
期末现金及现金等价物余额902,060,508.84662,232,173.6676,571,156.45965,203,128.59
补充资料:
现金及现金等价物的净增加额--302,970,954.99--1,888,443,899.38
最新报告期:2025-08-29
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
华西证券崔文亮,徐顺利0.210.210.212025-08-29
中金公司张琎,吴婉桦0.520.54--2025-08-28
TOP↑